000 | 01278 a2200373 4500 | ||
---|---|---|---|
005 | 20250518033559.0 | ||
264 | 0 | _c20190916 | |
008 | 201909s 0 0 ger d | ||
022 | _a1613-7671 | ||
024 | 7 |
_a10.1007/s00508-019-1455-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrath, Helmut | |
245 | 0 | 0 |
_a[Smoking, alcohol and diabetes (Update 2019)]. _h[electronic resource] |
260 |
_bWiener klinische Wochenschrift _cMay 2019 |
||
300 |
_a67-70 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAlcohol Drinking _xadverse effects |
650 | 0 | 4 |
_aBenzazepines _xtherapeutic use |
650 | 0 | 4 |
_aBupropion _xtherapeutic use |
650 | 0 | 4 | _aDiabetes Mellitus |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aNicotine |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aQuinoxalines |
650 | 0 | 4 |
_aSmoking _xadverse effects |
650 | 0 | 4 |
_aSmoking Cessation _xmethods |
650 | 0 | 4 | _aTobacco Use Cessation Devices |
650 | 0 | 4 |
_aVarenicline _xtherapeutic use |
700 | 1 | _aKaser, Susanne | |
700 | 1 | _aTatschl, Christian | |
700 | 1 | _aFasching, Peter | |
773 | 0 |
_tWiener klinische Wochenschrift _gvol. 131 _gno. Suppl 1 _gp. 67-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00508-019-1455-z _zAvailable from publisher's website |
999 |
_c29583852 _d29583852 |